The emerging roles of artificial intelligence in cancer drug development and precision therapy

Biomed Pharmacother. 2020 Aug:128:110255. doi: 10.1016/j.biopha.2020.110255. Epub 2020 May 20.

Abstract

Artificial intelligence (AI) has strong logical reasoning ability and independent learning ability, which can simulate the thinking process of the human brain. AI technologies such as machine learning can profoundly optimize the existing mode of anticancer drug research. But at present AI also has its relative limitation. In this paper, the development of artificial intelligence technology such as deep learning and machine learning in anticancer drug research is reviewed. At the same time, we look forward to the future of AI.

Keywords: Anticancer therapy; Artificial intelligence; Drug development; Precision therapy.

Publication types

  • Review

MeSH terms

  • Animals
  • Antigens, Neoplasm / metabolism
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Artificial Intelligence*
  • Clinical Decision-Making
  • Drug Development*
  • Drug Resistance, Neoplasm
  • Humans
  • Immunotherapy
  • Molecular Targeted Therapy
  • Neoplasms / genetics
  • Neoplasms / immunology
  • Neoplasms / metabolism
  • Neoplasms / therapy*
  • Precision Medicine*
  • Radiotherapy, Computer-Assisted
  • Signal Transduction

Substances

  • Antigens, Neoplasm
  • Antineoplastic Agents